Neurodevelopmental disorders such as Childhood Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD), and Global Developmental Delay (GDD)
Conditions
Interventions
Control Group:Conventional Rehabilitation
Experimental Group:Conventional Rehabilitation + Digital Psychomotor Rehabilitation Therapy
Sponsors
Nanjing Children's Hospital
Eligibility
Sex/Gender
All
Age
4 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1.Attention Deficit/Hyperactivity Disorder (ADHD): Must meet the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), presenting symptoms of inattention and hyperactivity/impulsivity, which cause significant impacts on daily functions (e.g., learning, social interaction). 2.Autism Spectrum Disorder (ASD): Must meet the diagnostic criteria specified in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) or by the World Health Organization (WHO), with core symptoms including deficits in social communication/interaction and repetitive/restricted behaviors. 3.Age range: 4-12 years old in the Autism Spectrum Disorder (ASD) group, and 6-14 years old in the Attention Deficit Hyperactivity Disorder (ADHD) group. 4.Children are required to have a certain foundation in communication or motor skills (e.g., being able to understand simple instructions) to ensure their ability to participate in therapeutic interventions. Family Support: Parents/guardians must be able to cooperate with the study timeline (e.g., bringing the child to follow-up visits on time, completing homework tasks) and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Comorbidity with severe intellectual disability (IQ < 70), epilepsy, genetic metabolic diseases, organic brain injury, or other conditions that may affect the study results; presence of severe emotional disorders (e.g., major depression, anxiety attacks) or other mental illnesses (e.g., schizophrenia). 2.Physical functional impairments (e.g., severe motor dysfunction) that prevent participation in psychomotor therapy (e.g., inability to complete movement training); presence of aggressive behavior, self-injurious behavior, or severe non-compliance with treatment, which may affect study safety or data collection. 3.Having participated in other relevant clinical trials within the past 6 months, or currently receiving interventions that may affect the study results (e.g., high-dose psychotropic medications, other forms of behavioral interventions).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| For the ASD group, the assessments were conducted using the CBCL, CARS, ABC scales, and ATEC; ;For the ADHD group, the assessments included the SNAP-IV, the Emotional and Behavioral Score of the Parent; | — |
Countries
China
Contacts
Public ContactSunyaojin
Nanjing Children's Hospital
Outcome results
None listed